Rare Brain Disease in 大港開唱 Organizer: Symptoms & Treatment
- Doris, the curator behind Hong Kong’s long-running music festival, Big Big Fun, has been diagnosed with Moyamoya disease, a rare and progressive cerebrovascular disorder.
- Moyamoya disease, as described by the Rare Disease Hong Kong foundation and detailed in reports from the South China Morning Post and other sources, involves the blockage of...
- Doris discovered her condition during a routine health check, a discovery made more poignant by the fact that her mother also succumbed to the same illness.
Rare Brain Disorder Impacts Hong Kong Concert Organizer, Highlights Challenges of Diagnosis and Treatment
Doris, the curator behind Hong Kong’s long-running music festival, Big Big Fun, has been diagnosed with Moyamoya disease, a rare and progressive cerebrovascular disorder. The revelation comes as her husband, Freddy Lin, frontman of the band Shinning, has stepped back from a political career to support her, relocating with her to Finland. The case underscores the difficulties faced by those living with rare diseases, particularly in accessing timely diagnosis and appropriate care.
Moyamoya disease, as described by the Rare Disease Hong Kong foundation and detailed in reports from the South China Morning Post and other sources, involves the blockage of arteries at the base of the brain. This blockage triggers the growth of tiny, fragile blood vessels that attempt to compensate, creating a “smoky” or “hazy” appearance on imaging scans – hence the name, which translates to “moyamoya” in Japanese, meaning “something like a puff of smoke.”
Doris discovered her condition during a routine health check, a discovery made more poignant by the fact that her mother also succumbed to the same illness. This personal history prompted Lin to forgo his re-election campaign and accompany his wife to Finland, where she has taken on a representative role. Despite the move, Doris expressed a sense of anxiety returning to Hong Kong, likely due to concerns about access to specialized medical care.
Currently, there is no cure for Moyamoya disease. Treatment focuses on managing symptoms and preventing complications, primarily through surgical procedures aimed at restoring blood flow to the brain. According to the National Institute of Neurological Disorders and Stroke, the most common surgical approach involves creating a bypass using a superficial temporal artery and a branch of the middle cerebral artery. While these procedures can alleviate symptoms, they do not halt the progression of the disease.
The presentation of Moyamoya disease varies depending on age. In children, symptoms often include transient ischemic attacks or stroke, while adults are more likely to experience intracranial hemorrhage, presenting with sudden, severe headaches. Other symptoms can include muscle weakness, paralysis, seizures, sensory disturbances, and cognitive impairment. The disease is more prevalent in individuals of Asian descent, though it can occur in people of any ethnicity.
The Rare Disease Hong Kong organization, established in 2014, plays a crucial role in advocating for patients with rare conditions, promoting public awareness, and fostering collaboration between patients, families, healthcare professionals, and researchers. The foundation aims to improve policies and services for those affected by rare diseases, ensuring equal access to healthcare, social support, and education.
Doris’s experience highlights the importance of early detection and proactive management of Moyamoya disease. While there is no single solution, focusing on lifestyle adjustments and symptom management can significantly improve quality of life. The case also underscores the emotional and logistical challenges faced by individuals and families navigating rare disease diagnoses, and the critical need for continued research and support networks.
As awareness of rare diseases grows, organizations like Rare Disease Hong Kong are working to bridge the gap between patients, and resources. For those affected by Moyamoya disease, ongoing monitoring and collaboration with medical specialists are essential to navigate the complexities of this challenging condition.
